SE456135B - Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav - Google Patents
Lekemedelspreparat med antinikotinverkan och forfarande for framstellning deravInfo
- Publication number
- SE456135B SE456135B SE8305535A SE8305535A SE456135B SE 456135 B SE456135 B SE 456135B SE 8305535 A SE8305535 A SE 8305535A SE 8305535 A SE8305535 A SE 8305535A SE 456135 B SE456135 B SE 456135B
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- carrier material
- composition according
- polymeric carrier
- modified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/16—Two dimensionally sectional layer
- Y10T428/163—Next to unitary web or sheet of equal or greater extent
- Y10T428/164—Continuous two dimensionally sectional layer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24802—Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.]
- Y10T428/2481—Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.] including layer of mechanically interengaged strands, strand-portions or strand-like strips
- Y10T428/24818—Knitted, with particular or differential bond sites or intersections
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU3425002 | 1982-02-22 | ||
SU3425001 | 1982-03-16 | ||
SU3470509 | 1982-06-07 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8305535D0 SE8305535D0 (sv) | 1983-10-07 |
SE8305535L SE8305535L (sv) | 1983-10-07 |
SE456135B true SE456135B (sv) | 1988-09-12 |
Family
ID=27356396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8305535A SE456135B (sv) | 1982-02-22 | 1983-10-07 | Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav |
Country Status (7)
Country | Link |
---|---|
US (1) | US4971079A (de) |
JP (1) | JPS59500217A (de) |
CH (1) | CH658594A5 (de) |
DE (1) | DE3332429T1 (de) |
GB (1) | GB2125699B (de) |
SE (1) | SE456135B (de) |
WO (1) | WO1983002892A1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8317576D0 (en) * | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
JO1560B1 (en) * | 1989-01-21 | 1991-11-27 | الشركة العربية لصناعة الأدوية المساهمة المحدودة | Mouthwash to prevent smoking |
US5488962A (en) * | 1990-10-10 | 1996-02-06 | Perfetti, S.P.A. | Chewing gum which is a substitute for tobacco smoke |
AU9138891A (en) * | 1990-12-14 | 1992-07-08 | Steven J. Mondre | Nicotine-containing dental floss |
US5414005A (en) * | 1993-10-28 | 1995-05-09 | Dynagen, Inc. | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation |
US5780051A (en) * | 1992-04-02 | 1998-07-14 | Dynagen, Inc. | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
TW261531B (de) * | 1993-10-28 | 1995-11-01 | Dynagen Inc | |
US5666979A (en) * | 1994-09-29 | 1997-09-16 | Chase; Gene | Cigar substitute |
US5875786A (en) * | 1994-09-29 | 1999-03-02 | Chase; Gene | Cigar substitute |
US5662919A (en) * | 1994-11-21 | 1997-09-02 | Alcon Laboratories, Inc. | Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds |
EP0937077B1 (de) | 1996-10-30 | 2006-05-17 | Pfizer Inc. | Pyridon-kondensierte azabicyclische- oder cytisin-derivate, ihre herstellung und verwendung in der suchttherapie |
US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
US6087376A (en) * | 1997-02-05 | 2000-07-11 | University Of Kentucky Research Foundation | Use of lobeline compounds in the treatment of central nervous system diseases and pathologies |
US5830904A (en) * | 1997-02-05 | 1998-11-03 | University Of Kentucky Research Foundation | Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders |
AUPO897997A0 (en) * | 1997-09-04 | 1997-09-25 | King, Michael Glenn | Improved compositions and methods for the control of smoking |
ES2141024B1 (es) * | 1997-10-03 | 2000-10-16 | Manzanares Jesus Mari Gonzalez | Preparado de accion antinicotinica. |
WO2000004882A1 (en) * | 1998-07-21 | 2000-02-03 | Alpenstock Holdings Limited | Formulations of anionic polysaccharides |
US6344222B1 (en) | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
US7163705B2 (en) | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
US7935362B2 (en) | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
US6582738B2 (en) | 1999-09-13 | 2003-06-24 | Deseret Laboratories, Inc. | Process for preparing chewing gum containing a nutritional supplement |
US6322828B1 (en) | 1999-09-13 | 2001-11-27 | Deseret Laboratories, Inc. | Process for manufacturing a pharmaceutical chewing gum |
WO2001021147A1 (en) | 1999-09-20 | 2001-03-29 | Mastercare | Diet and weight control gum and sucker |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
WO2001089476A1 (en) * | 2000-05-19 | 2001-11-29 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
US6534527B2 (en) | 2000-06-02 | 2003-03-18 | Phytos, Inc. | Edible herbal compositions for relieving nicotine craving |
US7115288B2 (en) | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
DE10037983B4 (de) * | 2000-08-03 | 2006-04-13 | Stefan Zikeli | Polymerzusammensetzung und daraus hergestellter Formkörper mit einem Gehalt an Alkaloid |
US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
WO2004056363A2 (en) | 2002-12-20 | 2004-07-08 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
WO2005046363A2 (en) | 2003-11-07 | 2005-05-26 | U.S. Smokeless Tobacco Company | Tobacco compositions |
US20050234024A1 (en) * | 2004-04-14 | 2005-10-20 | Clarke David E | Materials and methods for the treatment of ulcerative colitis |
US20060211649A1 (en) * | 2005-03-21 | 2006-09-21 | Eric Marchewitz | Use of cytisine for enhancing physical performance |
WO2007041035A2 (en) * | 2005-09-30 | 2007-04-12 | Wm. Wrigley Jr. Company | Oral composition and method for stress reduction associated with smoking cessation |
CA2646942C (en) | 2006-03-16 | 2014-07-29 | Niconovum Ab | Improved snuff composition |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
US8506936B2 (en) * | 2008-11-25 | 2013-08-13 | Watson Laboratories, Inc. | Stabilized nicotine chewing gum |
CN106390128B (zh) | 2011-01-10 | 2022-07-08 | 伊沃恩有限公司 | β-肾上腺素能反向激动剂用于戒烟的用途 |
US20160199315A1 (en) * | 2013-08-23 | 2016-07-14 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
PL408608A1 (pl) | 2014-06-18 | 2015-12-21 | Pharmacia Polonica Spółka Z Ograniczoną Odpowiedzialnością | Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania |
EP3598968A1 (de) * | 2018-07-23 | 2020-01-29 | Adamed Pharma S.A. | Feste pharmazeutische cytisin-zusammensetzung |
CA3153405A1 (en) | 2019-09-12 | 2021-03-18 | Achieve Life Sciences, Inc. | Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL255047A (de) * | 1959-08-21 | |||
FR4627M (de) * | 1965-05-14 | 1966-11-28 | ||
NL167303C (nl) * | 1970-07-22 | Leo Ab | Vormstukken van kauwgom, bestaande uit een kauwgomba- sismassa, een tabaksalkaloide en eventueel andere ge- bruikelijke bestanddelen van kauwgom. | |
US3877468A (en) * | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
US3901248A (en) * | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
US3818107A (en) * | 1972-09-28 | 1974-06-18 | Brook D | Chewing gum with sustained flavor release compositions |
JPS5716773B2 (de) * | 1974-05-17 | 1982-04-07 | ||
CA1087905A (en) * | 1976-02-02 | 1980-10-21 | Donald A.M. Mackay | Long-lasting flavored chewing gum including chalk- free gum base |
US4151270A (en) * | 1977-09-26 | 1979-04-24 | Wm. Wrigley Jr. Company | Chewing gum composition |
US4195645A (en) * | 1978-03-13 | 1980-04-01 | Celanese Corporation | Tobacco-substitute smoking material |
US4276890A (en) * | 1979-04-11 | 1981-07-07 | Fichera Anthony T | Tobacco smoking inhibitor |
-
1983
- 1983-02-22 CH CH5780/83A patent/CH658594A5/de not_active IP Right Cessation
- 1983-02-22 GB GB08327748A patent/GB2125699B/en not_active Expired
- 1983-02-22 DE DE833332429T patent/DE3332429T1/de not_active Withdrawn
- 1983-02-22 WO PCT/SU1983/000004 patent/WO1983002892A1/en active Application Filing
- 1983-02-22 JP JP83501017A patent/JPS59500217A/ja active Pending
- 1983-10-07 SE SE8305535A patent/SE456135B/sv not_active IP Right Cessation
-
1987
- 1987-03-05 US US07/023,914 patent/US4971079A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3332429T1 (de) | 1984-01-26 |
WO1983002892A1 (en) | 1983-09-01 |
SE8305535D0 (sv) | 1983-10-07 |
GB2125699A (en) | 1984-03-14 |
US4971079A (en) | 1990-11-20 |
CH658594A5 (de) | 1986-11-28 |
JPS59500217A (ja) | 1984-02-16 |
SE8305535L (sv) | 1983-10-07 |
GB8327748D0 (en) | 1983-11-16 |
GB2125699B (en) | 1986-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE456135B (sv) | Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav | |
DE69610323T2 (de) | Sich schnell im munde auflösende zusammensetzungen für dopaminagonisten | |
US3870794A (en) | Treatment of certain emotional disorders with nicotine compounds | |
JPH04501425A (ja) | ロラタジン、イブプロフェンおよびプソイドエフェドリンを含む薬剤組成物 | |
JPS591412A (ja) | 脳血管不全症処置用固形製剤 | |
WO2003018015A1 (de) | Elektronischer baustein | |
SK20099A3 (en) | Treatment of upper airway allergic responses with a combination of histamine receptor antagonists | |
HU229565B1 (hu) | Buprenorfin tartalmú, fájdalomcsillapító hatású gyógyszerkészítmények | |
RU2002106399A (ru) | Составы моксифлоксацина, содержащие поваренную соль | |
JPH11501282A (ja) | コリン受容体作用薬及び拮抗薬としてのエピバチジン及びその誘導体 | |
AU693144B2 (en) | Taste masked composition containing a drug/polymer complex | |
JPS5874608A (ja) | アヘン製剤に関して末梢「きつ」抗作用を有する製薬組成物 | |
JPH0729916B2 (ja) | 鎮痛性を有する医薬組成物 | |
Furtado et al. | Development and characterization of orodispersible tablets of famotidine containing a subliming agent | |
RU2261098C2 (ru) | Перорально распадающаяся композиция, содержащая миртазапин | |
JPH037223A (ja) | 吸入用喘息治療剤 | |
IE85899B1 (en) | New oral drug forms | |
US3359166A (en) | Method of effecting analgesia | |
WO1995007282A1 (fr) | Antidepresseur | |
JP2003503459A (ja) | パラセタモール及びブスピロンを含有した鎮痛性作用を有する新規医薬組成物 | |
DE2605243A1 (de) | Pyrazolessigsaeurehaltiges arzneimittel | |
JP2001511159A (ja) | オキシムを含むシナプス機能障害の処置用医薬組成物 | |
JPH0232020A (ja) | モルフィン鎮痛治療における耐性発現の抑制方法および薬剤 | |
AU1045695A (en) | Use of lobeline for the treatment of nicotine withdrawal | |
CS199202B2 (en) | Method of producing gelatine capsules to be bitten up |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8305535-0 Effective date: 19940910 Format of ref document f/p: F |